|
WHI-OS N = 68,169 |
|
Antidepressant use at baseline |
No antidepressant use at baseline |
|
N (%) |
N (%) |
Antidepressant use at year 3 |
3321 (4.9 %) |
3083 (4.5 %) |
No antidepressant use at year 3 |
1468 (2.2 %) |
60297 (88.5 %) |
|
Presence of elevated symptoms at baseline |
No presence of elevated symptoms at baseline |
|
N (%) |
N (%) |
Presence of elevated symptoms at year 3 |
4348 (6.4 %) |
6333 (9.3 %) |
No presence of elevated symptoms at year 3 |
5458 (8.0 %) |
52030 (76.3 %) |
|
Baseline |
Year 3 |
|
Mean (SD) |
Mean (SD) |
BMI |
26.80 (5.5) |
27.09 (5.6) |
|
WHI-CT N = 52,326 |
|
Antidepressant use at baseline |
No antidepressant use at baseline |
|
N (%) |
N (%) |
Antidepressant use at year 3 |
2031 (3.9 %) |
1979 (3.8 %) |
No antidepressant use at year 3 |
1156 (2.2 %) |
47160 (90.1 %) |
|
Baseline |
Year 3 |
|
Mean (SD) |
Mean (SD) |
BMI |
28.54 (5.7) |
28.78 (5.9) |